Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Regulatory Peptides|December 30, 1986
Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in ratsF Makovec, M Bani, R Chistè, et al.
Arzneimittel-Forschung|February 24, 2001
Bioavailability and pharmacokinetic profile of dihydroergotoxine from a tablet and from an oral solution formulationI Setnikar, K Schmid, L C Rovati, et al.
Arzneimittel-Forschung|January 1, 1985
New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activityF Makovec, R Chistè, M Bani, et al.
Rheumatology International|March 17, 2005
Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot studyJ D Ringe, A Dorst, H Faber, et al.
Arzneimittel-Forschung|October 1, 1987
Loxiglumide protects against experimental pancreatitisI Setnikar, M Bani, R Cereda, et al.
Arzneimittel-Forschung|September 14, 1999
Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patchI Setnikar, L C Rovati, A Santoro, et al.
Arzneimittel-Forschung|October 1, 1987
Anticholecystokinin activities of loxiglumideI Setnikar, M Bani, R Cereda, et al.
Arzneimittel-Forschung|January 1, 1979
Studies on the mechanism of action of protacine (CR 604), a new non-steroidal anti-inflammatory agentR R Vidal y Plana, F Makovec, A Cifarelli, et al.
Arzneimittel-Forschung|December 22, 1999
Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studiesL C Rovati, K Schmid, G Giacovelli, et al.
Arzneimittel-Forschung|July 1, 1997
Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrixI Setnikar, L C Rovati, J J Thebault, et al.
Pageof 8